Citadel Advisors’s Signify Health, Inc. SGFY Stock Holding History

Citadel Advisors’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,000	Closed	-$57.3K	–	16024
2022 Q4	$57.3K	Sell	2,000 -16,700	-89%	-$482K	﹤0.01%	11956
2022 Q3	$545K	Sell	18,700 -19,600	-51%	-$451K	﹤0.01%	8278
2022 Q2	$529K	Buy	38,300 +9,400	+33%	+$132K	﹤0.01%	8521
2022 Q1	$525K	Sell	28,900 -32,500	-53%	-$466K	﹤0.01%	9273
2021 Q4	$873K	Buy	61,400 +14,300	+30%	+$221K	﹤0.01%	8284
2021 Q3	$842K	Buy	47,100 +33,700	+251%	+$867K	﹤0.01%	8575
2021 Q2	$408K	Sell	13,400 -1,100	-8%	-$30.2K	﹤0.01%	10517
2021 Q1	$424K	Buy	+14,500	New	+$449K	﹤0.01%	10048

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Citadel Advisors's SGFY Position: Q1 2023 in Review

Citadel Advisors sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 124,376 shares — an estimated $3.56M sold.

Citadel Advisors first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $56.8M in Q1 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Citadel Advisors reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Citadel Advisors sold 124,376 Signify Health, Inc. shares in Q1 2023, an estimated $3.56M.
Citadel Advisors first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
Citadel Advisors's Signify Health, Inc. position peaked at $56.8M in Q1 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.